CHARACTERISTICS | CREE* (N = 30) | NON-CREE* (N = 51) | PVALUE |
---|---|---|---|
Male sex, n (%) | 15 (50.0) | 28 (54.9) | .81 |
Median age (range), y | 59.1 (35–81) | 67.9 (33–84) | .0035 |
Median time of follow-up (range), mo | 1.5 (0–20) | 2.0 (0–14) | .45 |
Median duration of diabetes (range), y† | 16.0 (3–30) | 15.0 (5–50) | .61 |
Comorbidities noted in chart, n (%) | |||
• Hypertension | 29 (96.7) | 42 (82.4) | .25 |
• Cardiac disease | 11 (36.7) | 21 (41.2) | .81 |
• Peripheral vascular disease | 6 (20.0) | 12 (23.5) | .79 |
• Retinopathy | 13 (43.3) | 16 (31.4) | .28 |
• Peripheral neuropathy | 5 (16.7) | 12 (23.5) | .46 |